| Paul Denis Leger, MD | |
|
3800 Reservoir Rd Nw Lccc, Podium B, Washington, DC 20007-2113 | |
| (202) 444-2223 | |
| Not Available |
| Full Name | Paul Denis Leger |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 27 Years |
| Location | 3800 Reservoir Rd Nw Lccc, Podium B, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316380264 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medstar Georgetown University Hospital | Washington, DC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mgmc Llc | 9537073119 | 412 |
News Archive
As we gain more and more information about the coronavirus and COVID-19, we seem to have less and less understanding of how the disease works and how prevalent it is in areas around the country and world.
Molecular technology developed by a University of Colorado at Boulder professor to probe extreme life forms in undersea hydrothermal vents has been used to identify unexpected bacteria strains in the lung fluid of Denver children suffering from cystic fibrosis, findings that may lead to more effective therapies.
A VOA News editorial by the U.S. government reflects on last month's International AIDS Conference-AIDS 2010, including key advancements such as the vaginal microbicide gel found to offer women some protection against HIV infection as well discussions about funding for the fight against HIV/AIDS and how the "criminalization of drug abuse and persecution of homosexuals" in the world is compromising efforts to prevent the spread of the disease.
[T]he latest report from the green-eyeshade experts at Milliman does include a few surprises about what is — and isn't — driving [health care] costs higher. ... Last year, health costs rose by 7.3 percent, which is the slowest rate of increase in more than a decade. By comparison, though, the Consumer Price Index rose only about 1.5 percent last year.... So what's driving the increases?
Findings from a study carried out in mice suggest that an intermittent dosing strategy may be the answer to combating lethal tumor resistance to the BRAF inhibitor vemurafenib, in patients with late-stage BRAF-mutated melanoma.
› Verified 3 days ago
| Entity Name | Mgmc Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891797148 PECOS PAC ID: 9537073119 Enrollment ID: O20031220000056 |
News Archive
As we gain more and more information about the coronavirus and COVID-19, we seem to have less and less understanding of how the disease works and how prevalent it is in areas around the country and world.
Molecular technology developed by a University of Colorado at Boulder professor to probe extreme life forms in undersea hydrothermal vents has been used to identify unexpected bacteria strains in the lung fluid of Denver children suffering from cystic fibrosis, findings that may lead to more effective therapies.
A VOA News editorial by the U.S. government reflects on last month's International AIDS Conference-AIDS 2010, including key advancements such as the vaginal microbicide gel found to offer women some protection against HIV infection as well discussions about funding for the fight against HIV/AIDS and how the "criminalization of drug abuse and persecution of homosexuals" in the world is compromising efforts to prevent the spread of the disease.
[T]he latest report from the green-eyeshade experts at Milliman does include a few surprises about what is — and isn't — driving [health care] costs higher. ... Last year, health costs rose by 7.3 percent, which is the slowest rate of increase in more than a decade. By comparison, though, the Consumer Price Index rose only about 1.5 percent last year.... So what's driving the increases?
Findings from a study carried out in mice suggest that an intermittent dosing strategy may be the answer to combating lethal tumor resistance to the BRAF inhibitor vemurafenib, in patients with late-stage BRAF-mutated melanoma.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul Denis Leger, MD 3800 Reservoir Rd Nw Lccc, Podium B, Washington, DC 20007-2113 Ph: (202) 444-2223 | Paul Denis Leger, MD 3800 Reservoir Rd Nw Lccc, Podium B, Washington, DC 20007-2113 Ph: (202) 444-2223 |
News Archive
As we gain more and more information about the coronavirus and COVID-19, we seem to have less and less understanding of how the disease works and how prevalent it is in areas around the country and world.
Molecular technology developed by a University of Colorado at Boulder professor to probe extreme life forms in undersea hydrothermal vents has been used to identify unexpected bacteria strains in the lung fluid of Denver children suffering from cystic fibrosis, findings that may lead to more effective therapies.
A VOA News editorial by the U.S. government reflects on last month's International AIDS Conference-AIDS 2010, including key advancements such as the vaginal microbicide gel found to offer women some protection against HIV infection as well discussions about funding for the fight against HIV/AIDS and how the "criminalization of drug abuse and persecution of homosexuals" in the world is compromising efforts to prevent the spread of the disease.
[T]he latest report from the green-eyeshade experts at Milliman does include a few surprises about what is — and isn't — driving [health care] costs higher. ... Last year, health costs rose by 7.3 percent, which is the slowest rate of increase in more than a decade. By comparison, though, the Consumer Price Index rose only about 1.5 percent last year.... So what's driving the increases?
Findings from a study carried out in mice suggest that an intermittent dosing strategy may be the answer to combating lethal tumor resistance to the BRAF inhibitor vemurafenib, in patients with late-stage BRAF-mutated melanoma.
› Verified 3 days ago
Dr. Adefolaju Oketokun, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1629 K Street Nw, Suite 300, Washington, DC 20006 Phone: 202-636-1360 Fax: 202-636-5137 | |
Dr. Uzoamaka Theodora Nwaogwugwu, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2041 Georgia Avenue Nw, Washington, DC 20060 Phone: 202-865-7677 | |
Ms. Sruthi Nukalapati Reddy, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Road Nw, 6 Phc, Washington, DC 20007 Phone: 202-444-8123 | |
Dr. Kaustubh Subhash Yadwadkar, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Cg201, Washington, DC 20007 Phone: 304-206-7595 | |
Dr. Monica Vohra, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1525 7th St Nw, Washington, DC 20001 Phone: 202-386-7020 Fax: 202-265-1970 | |
Anteneh A Tesfaye, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw Ste C2151, Washington, DC 20010 Phone: 202-877-6998 Fax: 202-877-8909 | |
Erica Nakajima, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5255 Loughboro Rd Nw Fl 1, Washington, DC 20016 Phone: 202-660-6500 |